OIA
BPMC

OneDigital Investment Advisors’s Blueprint Medicines BPMC Stock Holding History

OneDigital Investment Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,300
Closed -$70K – 697
2020
Q3 		$70K Buy
+2,300
New +$177K ﹤0.01% 597

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

OneDigital Investment Advisors's BPMC Position: Q1 2021 in Review

OneDigital Investment Advisors sold out of Blueprint Medicines (BPMC) in Q1 2021, closing a stake of 3,246 shares — an estimated $364K sold.

OneDigital Investment Advisors first reported a position in BPMC in Q3 2020 and held it in 2 quarters. The position peaked at $364K in Q4 2020. 264 funds tracked by Wall St. Rank hold BPMC as of Q1 2021.

  • OneDigital Investment Advisors reported no remaining Blueprint Medicines position as of Q1 2021 after selling out during the quarter.
  • OneDigital Investment Advisors sold 3,246 Blueprint Medicines shares in Q1 2021, an estimated $364K.
  • OneDigital Investment Advisors first reported a position in Blueprint Medicines in Q3 2020 and held it in 2 quarters.
  • OneDigital Investment Advisors's Blueprint Medicines position peaked at $364K in Q4 2020.
  • 264 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2021.

Based on OneDigital Investment Advisors's 13F filing for Q1 2021, filed 10 May 2021.